Bharat Biotech on Wednesday received the World Health Organization’s emergency use listing for its coronavirus vaccine, Covaxin.

The decision was taken by a technical advisory group of the global health body that met earlier in the day.

Emergency use listing is a procedure by the global health body to approve vaccines and other products for use during public health emergencies. The duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer.

On Wednesday, the World Health Organization said that sufficient data was not available for Covaxin on vaccination of pregnant women. It added that the information would assess the vaccine’s safety or efficacy during pregnancy.

The world body said that there are plans to conduct studies on pregnant women.

The global health body also said that Covaxin was found to be 78% effective against the coronavirus in case of all severities. The WHO also advised a gap of 14 or more days between the two shots.

It added that Covaxin was “extremely suitable for low-and…

Read more

donate button
Please choose the donation payment system

Donation Information

I would like to make a donation in the amount of:


I would like this donation to repeat each month

Tribute Gift

Check here to donate in honor or memory of someone

Donor Information

Add me to your mailing list


Leave a Reply

Your email address will not be published. Required fields are marked *